xbox高清视频线,国产精品偷伦视频免费观看了,中文字幕在线播放,亚瑟 中文字幕

關鍵詞:
  首頁 > 美迪醫訊 > 瓣膜搭橋而不是手術替換  

瓣膜搭橋而不是手術替換

【?2008-09-22 發布?】 美迪醫訊
美迪網領先的醫療器械電子商務平臺

一個新的研究成果顯示低損傷瓣膜搭橋是一個安全有效在高風險的高齡主動脈狹窄患者中替代傳統的心臟瓣膜置換手術的方式。
這項研究稱,一個為狹窄的大動脈瓣膜搭橋的外科手術,要好于瓣膜置換手術,并能有效的修復血液從心臟流到身體的其他部位。研究者稱這個過程為大動脈瓣膜搭橋,這是一個對高風險的有主動脈狹窄癥狀的高齡患者重要的治療選擇。
在主動脈狹窄病例中,鈣質沉淀使得主動脈瓣膜狹窄,損害了心臟的供血能力。在瓣膜置換手術中外科醫生打開胸腔會使心臟停止跳動約90分鐘,打開主動脈切除舊的瓣膜并且縫入一個新的。搭橋的過程,無論如何是一個危害最小的手段而且不必停止心臟跳動。
“因為主動脈瓣膜置換在高齡患者中可能存在的風險的,幾乎有60%的顯示主動脈狹窄的征兆患者不能進行外科手術,”這項研究的負責人James S. Gammie談到,他主張這些病人可以從低損傷手術過程中受益。
為了給這些狹窄的主動脈瓣膜搭橋,外科醫生們從1970年起就在改良手術過程。大多數從心臟流出的血液通過軟管轉移到替代的瓣膜,其位置是靠近左心室的頂端到主動脈。這個外科手術工作通過兩肋間的切口進行。在早期的案例中,需要一個大的切口,這個過程在當時得到了修正。目前一個三英寸的切口就足夠了。
在2003-2007年中,31例高風險的主動脈狹窄患者進行了這種外科手術,患者平均年齡81歲,其中很多患者還有其他病癥,幾乎一半的患者拒絕傳統外科手術治療。在進行手術的初期,4位患者沒能在手術后幸存,目前連續進行的16例手術沒有死亡發生。
這個手術和主動脈心臟瓣膜置換手術傳統療法治療心臟血液流動障礙一樣有效。因為被損害的主動脈瓣膜仍舊在相應的部位。一些血液流動繼續流過心臟瓣膜流出。但是外科血液流動劑量顯示,在大多數患者中大約70%的心排血量通過新的橋接流動的。

Stenosis: Valve Bypass Instead of Replacement

A new study shows that the minimally-invasive valve bypass is a safe, effective alternative to conventional valve replacement in high-risk elderly patients with aortic stenosis. 19/09/2008

A surgical procedure that bypasses a narrowed aortic valve, rather than replacing it, effectively restores blood flow from the heart to the rest of the body, says a new study. The researchers conclude that the procedure, called aortic valve bypass, is an important treatment option for high-risk elderly patients with a condition called aortic stenosis.
In aortic stenosis, calcium deposits narrow the aortic valve and impair the heart's ability to pump blood. During valve replacement, the surgeon opens the chest, stops the heart for about 90 minutes, opens the aorta, cuts out the old valve and sews in a new one. The bypass procedure, however, can be performed in a minimally invasive way without stopping the heart.
"Because of the possible risks associated with aortic valve replacement in the elderly, almost 60 percent of patients with symptoms related to aortic stenosis are not referred to surgery," says lead researcher James S. Gammie. These patients could benefit from the minimal-invasive procedure, Gammie argues.
In order to bypass the narrowed aortic valve, surgeons have refined a procedure from the 1970s. Most of the blood flow from the heart is diverted through a tube containing a standard replacement valve that is placed near the apex of the left ventricle to the aorta. The surgeons work through an incision between two ribs. During the first cases, a large incision was needed. However, the procedure was modified this year, so that a three-inch opening is enough.
Between 2003 and 2007, the surgeons treated 31 high-risk aortic stenosis patients with aortic valve bypass surgery. Many of the patients also had other conditions. The average age was 81, and nearly half had been refused conventional surgery. Early in the series, four of the 31 patients did not survive the procedure, yet there were no deaths among the most recent 16 consecutive patients.
The procedure was as effective as conventional aortic valve replacement surgery at relieving the obstruction of blood leaving the heart. Because the impaired aortic valve was left in place, some blood flow continued through that valve. But postsurgical blood flow measurements indicated that in most patients, approximately 70 percent of cardiac output flowed through the new bypass.

 

本文關鍵字: 瓣膜搭橋 
收藏本文到: Digg Live Bookmark Facebook 百度搜藏 新浪ViVi 365Key網摘 天極網摘 和訊網摘 POCO網摘 QQ書簽

  《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢

我要評論:《瓣膜搭橋而不是手術替換》
匿名發表 我的名字: Email: 驗證碼: 點擊可刷新
 
    

  更多關于 瓣膜搭橋  的新聞

合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖
把美迪網放進收藏夾  把美迪醫療網介紹給我的朋友  給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303    美迪醫療網業務咨詢
互聯網藥品信息服務許可證:(滬)-經營性-2009-0003   中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8
 
公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號
營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081
消防排煙風機 華創商務網
美迪醫療網廣告業務聯系:021-51601230  產品咨詢業務聯系:021-51601230 傳真:021-56532303   美迪醫療網產品咨詢 本QQ僅咨詢廣告和會員業務,不咨詢產品和藥品等業務美迪醫療網推廣業務咨詢